Saliva-based lacosamide monitoring paves the way toward personalized epilepsy pharmacotherapy

Patient characteristics

Out of the 128 patients prescribed lacosamide, five individuals were excluded from the study. Four patients dropped the study, and one patient did not provide a sufficient saliva sample. As a result, the final study…

Continue Reading